Literature DB >> 18796627

The PHD fingers of MLL block MLL fusion protein-mediated transformation.

Andrew G Muntean1, Diane Giannola, Aaron M Udager, Jay L Hess.   

Abstract

Chromosomal translocations involving the mixed lineage leukemia (MLL) gene are associated with aggressive acute lymphoid and myeloid leukemias. These translocations are restricted to an 8.3-kb breakpoint region resulting in fusion of amino terminal MLL sequences in frame to 1 of more than 60 different translocation partners. The translocations consistently delete the plant homeodomain (PHD) fingers and more carboxyl terminal MLL sequences. The function of the PHD fingers is obscure and their specific role in transformation has not been explored. Here we show that inclusion of the PHD fingers in the MLL fusion protein MLL-AF9 blocked immortalization of hematopoietic progenitors. Inclusion of 2 or more PHD fingers reduced association with the Hoxa9 locus and suppressed Hoxa9 up-regulation in hematopoietic progenitors. These data provide an explanation for why MLL translocation breakpoints exclude the PHD fingers and suggest a possible role for these domains in regulating the function of wild-type MLL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18796627      PMCID: PMC2597135          DOI: 10.1182/blood-2008-01-134056

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  Plat-E: an efficient and stable system for transient packaging of retroviruses.

Authors:  S Morita; T Kojima; T Kitamura
Journal:  Gene Ther       Date:  2000-06       Impact factor: 5.250

2.  ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation.

Authors:  Tatsuya Nakamura; Toshiki Mori; Shinichiro Tada; Wladyslaw Krajewski; Tanya Rozovskaia; Richard Wassell; Garrett Dubois; Alexander Mazo; Carlo M Croce; Eli Canaani
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

3.  Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.

Authors:  Bernd B Zeisig; Tom Milne; María-Paz García-Cuéllar; Silke Schreiner; Mary-Ellen Martin; Uta Fuchs; Arndt Borkhardt; Sumit K Chanda; John Walker; Richard Soden; Jay L Hess; Robert K Slany
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

4.  Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9.

Authors:  Paul M Ayton; Michael L Cleary
Journal:  Genes Dev       Date:  2003-09-02       Impact factor: 11.361

5.  Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality.

Authors:  T Rozovskaia; E Feinstein; O Mor; R Foa; J Blechman; T Nakamura; C M Croce; G Cimino; E Canaani
Journal:  Oncogene       Date:  2001-02-15       Impact factor: 9.867

6.  Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells.

Authors:  K Fair; M Anderson; E Bulanova; H Mi; M Tropschug; M O Diaz
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

7.  MLL targets SET domain methyltransferase activity to Hox gene promoters.

Authors:  Thomas A Milne; Scott D Briggs; Hugh W Brock; Mary Ellen Martin; Denise Gibbs; C David Allis; Jay L Hess
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

8.  Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression.

Authors:  Akihiko Yokoyama; Zhong Wang; Joanna Wysocka; Mrinmoy Sanyal; Deborah J Aufiero; Issay Kitabayashi; Winship Herr; Michael L Cleary
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

9.  E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases.

Authors:  Shweta Tyagi; Anna Lena Chabes; Joanna Wysocka; Winship Herr
Journal:  Mol Cell       Date:  2007-07-06       Impact factor: 17.970

10.  MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein.

Authors:  Zhen-Biao Xia; Melanie Anderson; Manuel O Diaz; Nancy J Zeleznik-Le
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 11.205

View more
  32 in total

1.  Grist for the MLL: how do MLL oncogenic fusion proteins generate leukemia stem cells?

Authors:  Tim C P Somervaille; Michael L Cleary
Journal:  Int J Hematol       Date:  2010-05-08       Impact factor: 2.490

2.  ECSASB2 mediates MLL degradation during hematopoietic differentiation.

Authors:  Jingya Wang; Andrew G Muntean; Jay L Hess
Journal:  Blood       Date:  2011-12-15       Impact factor: 22.113

Review 3.  The pathogenesis of mixed-lineage leukemia.

Authors:  Andrew G Muntean; Jay L Hess
Journal:  Annu Rev Pathol       Date:  2011-10-17       Impact factor: 23.472

4.  Epigenetic dysregulation in cancer.

Authors:  Andrew G Muntean; Jay L Hess
Journal:  Am J Pathol       Date:  2009-08-28       Impact factor: 4.307

5.  Reemergence of translocation t(11;19)(q23;p13.1) in the absence of clinically overt leukemia.

Authors:  Suguru Uemura; Akihiro Tamura; Atsuro Saito; Daiichiro Hasegawa; Nanako Nino; Takehito Yokoi; Teppei Tahara; Aiko Kozaki; Kenji Kishimoto; Toshiaki Ishida; Keiichiro Kawasaki; Takeshi Mori; Noriyuki Nishimura; Minenori Ishimae; Mariko Eguchi; Yoshiyuki Kosaka
Journal:  Int J Hematol       Date:  2017-07-01       Impact factor: 2.490

6.  Proteolytically cleaved MLL subunits are susceptible to distinct degradation pathways.

Authors:  Akihiko Yokoyama; Francesca Ficara; Mark J Murphy; Christian Meisel; Alpana Naresh; Issay Kitabayashi; Michael L Cleary
Journal:  J Cell Sci       Date:  2011-07-01       Impact factor: 5.285

Review 7.  Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers.

Authors:  Ping Chi; C David Allis; Gang Greg Wang
Journal:  Nat Rev Cancer       Date:  2010-07       Impact factor: 60.716

Review 8.  The molecular mechanics of mixed lineage leukemia.

Authors:  R K Slany
Journal:  Oncogene       Date:  2016-02-29       Impact factor: 9.867

9.  The PHD3 domain of MLL acts as a CYP33-regulated switch between MLL-mediated activation and repression .

Authors:  Sangho Park; Ute Osmers; Gayathree Raman; Rebecca H Schwantes; Manuel O Diaz; John H Bushweller
Journal:  Biochemistry       Date:  2010-08-10       Impact factor: 3.162

Review 10.  Diverse functions of PHD fingers of the MLL/KMT2 subfamily.

Authors:  Muzaffar Ali; Robert A Hom; Weston Blakeslee; Larissa Ikenouye; Tatiana G Kutateladze
Journal:  Biochim Biophys Acta       Date:  2013-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.